What Is TB-500?
TB-500 is a synthetic version of Thymosin Beta 4, a naturally occurring peptide that promotes cellular migration — essentially directing your body's repair cells to injury sites.
TB-500 is the other half of the most popular peptide stack in the recovery world. While BPC-157 gets more name recognition, TB-500 plays a fundamentally different and complementary role in tissue repair. If BPC-157 prepares the injury site for healing, TB-500 gets the repair cells there.
It's a synthetic version of a naturally occurring peptide called Thymosin Beta 4 — a protein your body already produces that's involved in cell migration, wound healing, and tissue repair.
What TB-500 Actually Is
Thymosin Beta 4 (Tβ4) is a small protein found in nearly every cell in your body. It was first identified in the thymus gland — hence the name — but it's produced throughout the body. It plays a major role in how your cells move, organize, and respond to injury.
TB-500 is a synthetic version of the active region of Thymosin Beta 4. It replicates the key functional segment of the natural protein, making it available as a supplemental peptide.
How TB-500 Works
TB-500's primary mechanism is promoting cellular migration — helping your body's repair cells physically get to where they're needed.
Actin Upregulation
TB-500 upregulates a protein called actin. Actin is one of the main structural proteins inside your cells. It forms the internal scaffolding — the cytoskeleton — that gives cells their shape and, critically, their ability to move.
When TB-500 increases actin production, cells become more structurally capable of migration. They can reorganize their internal framework, extend in a direction, and physically travel to an injury site.
Think of it this way: if repair cells are construction workers, actin is the road. TB-500 builds more road so the workers can reach the job site.
Cell Migration Signaling
Beyond building the structural capacity for movement, TB-500 acts as a directional signal. It helps repair cells know where to go. In animal studies, TB-500 has been shown to attract endothelial cells, keratinocytes, and other repair-involved cells to wound sites.
Blood Vessel Formation
Like BPC-157, TB-500 promotes angiogenesis — the growth of new blood vessels. New tissue needs blood supply. TB-500 supports the vascular infrastructure that makes repair possible.
Inflammation Regulation
TB-500 has demonstrated anti-inflammatory properties in research. It appears to help modulate the inflammatory response at injury sites — reducing excessive inflammation that can slow healing while still allowing the necessary inflammatory processes that initiate repair.
What the Research Shows
TB-500 / Thymosin Beta 4 research spans several areas:
Wound Healing (Animal Data)
Multiple animal studies have demonstrated accelerated wound healing with Thymosin Beta 4 and TB-500. Wounds closed faster, with improved tissue quality and less scarring. The peptide appeared to promote both the migration of repair cells and the formation of new blood vessels at the wound site.
Cardiac Repair (Animal Data)
Some of the most interesting research on Thymosin Beta 4 involves heart tissue. Animal studies showed that Tβ4 could activate cardiac progenitor cells after heart injury, potentially supporting heart muscle repair. This research attracted significant attention in the cardiology community, though it hasn't advanced to human treatment.
Corneal Healing (Human Data)
Thymosin Beta 4 has actually been studied in humans for corneal wound healing. Eye drop formulations showed promise in accelerating the healing of damaged corneal tissue. This is one of the few areas where the natural version of this peptide has human clinical data.
Tendon and Ligament Repair (Animal Data)
Animal studies show TB-500 accelerates tendon healing and may improve the structural quality of repaired tendon tissue. Combined with its blood vessel-promoting effects, it addresses a key limitation of tendon repair — poor blood supply.
Brain Injury (Animal Data)
Early animal research suggests Thymosin Beta 4 may have neuroprotective properties and could support recovery after traumatic brain injury. The peptide appeared to promote neurite outgrowth and reduce inflammation in brain tissue. This is preliminary but being actively researched.
TB-500 vs. BPC-157
People often ask which one to use. They do different things:
They're complementary, not competing. That's why the Wolverine blend (both together) is the most popular recovery stack.
How People Use TB-500
Subcutaneous Injection
TB-500 is administered by subcutaneous injection. Unlike BPC-157, it's not stable in stomach acid, so oral use isn't an option.
Common Protocols (Community-Derived)
A typical protocol discussed in the community:
- Loading phase: 2-5 mg twice per week for the first 4-6 weeks
- Maintenance phase: 2-5 mg once per week for another 4-6 weeks
- Some people inject near the injury site; others inject systemically
The front-loading approach is based on the idea that establishing higher initial levels helps jump-start the repair process, then maintenance keeps it going.
Cycling
Most people use TB-500 in cycles of 8-12 weeks rather than continuously. After a cycle, they take time off before starting again if needed.
Safety
TB-500 has a generally favorable safety profile in animal research:
- Thymosin Beta 4 is a naturally occurring protein in your body
- Animal studies have not shown significant toxicity at standard doses
- The corneal healing human studies reported minimal adverse effects
Commonly reported side effects (anecdotal from human use):
- Temporary lethargy or fatigue when first starting (usually resolves within a few days)
- Mild flu-like symptoms
- Headache
- Injection site irritation
The angiogenesis concern: Like BPC-157, TB-500 promotes blood vessel growth. The same theoretical caution applies — people with active cancers should be aware that promoting new blood vessel formation could theoretically support tumor growth. This hasn't been demonstrated in research, but it's worth knowing.
TB-500 is not FDA-approved for human use (outside of the corneal healing research context for Thymosin Beta 4).
The Bottom Line
TB-500 is a repair-logistics peptide. It doesn't heal tissue directly — it gets your body's repair cells to the injury and gives them the structural tools to do their job. By upregulating actin and promoting cellular migration, it addresses one of the key bottlenecks in healing: getting repair resources to where they're needed.
Paired with BPC-157, it forms the most widely used recovery stack in the peptide world. The research is primarily animal-based, with some human data for the natural Thymosin Beta 4 version. It's not a magic bullet, but for people dealing with injuries that aren't resolving, it targets a specific and logical piece of the healing puzzle.